Unpacking the Numbers: A Recap of Saipem’s Q4 2024 Earnings Call

Unpacking the Numbers: A Recap of Saipem’s Q4 2024 Earnings Call Description: Saipem SpA (OTCPK:SAPMF) recently held its Q4 2024 Earnings Conference Call on February 26, 2025, at 4:30 AM ET. The call featured key company executives such as Chief Executive Officer Alessandro Puliti and Chief Financial Officer Paolo Calcagnini.

Read More »

Breaking News: Cal-Maine Foods Inc. Strikes Deal with Founder’s Family!

Breaking News: Cal-Maine Foods Inc. Strikes Deal with Founder’s Family! RIDGELAND, Miss.–(BUSINESS WIRE)– Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”) today announced that it has entered into an agreement with members of the family of its founder Fred R. Adams, Jr., relating to the potential diversification of

Read More »

Breaking News: Hammer Group Unveils Bold Restructuring Plan and Fintech Expansion!

Breaking News: Hammer Group Unveils Bold Restructuring Plan and Fintech Expansion! Description: New Initiatives Include the Launch of the HammerPay Remittance Platform and the Upcoming HammerPay Global Payments Service for Seamless Cross-Border Settlements Sarasota, Florida–(Newsfile Corp. – February 25, 2025) – Hammer Technologies Holdings Corp. (OTC: HMMR) (“Hammer Group”) is

Read More »

Unlock the Power of Data with Data443’s Latest Launch: Introducing ClassiForAI – The Ultimate Solution for AI Classification!

Unlock the Power of Data with Data443’s Latest Launch: Introducing ClassiForAI – The Ultimate Solution for AI Classification! About Data443 Risk Mitigation, Inc. Data443 Risk Mitigation, Inc. (OTCPK: ATDS), also known as Data443, is a leading AI data security and privacy software company that specializes in providing solutions for “All

Read More »

Breaking Barriers: Femasys’ FemBloc Permanent Birth Control Clinical Trials Yield Positive Safety and Efficacy Results – A Peer-Reviewed Publication

Breaking Barriers: Femasys’ FemBloc Permanent Birth Control Clinical Trials Yield Positive Safety and Efficacy Results – A Peer-Reviewed Publication Description: Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both patients and practitioners. ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) — Femasys Inc., (Nasdaq:

Read More »

Breaking News: Finnovate Acquisition Corp. Delays Shareholder Meeting to March 17, 2025 at 10:00 AM Eastern Time!

Breaking News: Finnovate Acquisition Corp. Delays Shareholder Meeting to March 17, 2025 at 10:00 AM Eastern Time! Boston, MA, Feb. 25, 2025 (GLOBE NEWSWIRE) — Finnovate Acquisition Corp. (“Finnovate”) (OTC: “FNVUF”, “FNVTF”, “FNVWF”) announced today that its upcoming extraordinary general meeting of shareholders (the “Special Meeting”) to approve its proposed

Read More »

Breaking News: Kiniksa Pharmaceuticals Unveils Exciting New Drug for Recurrent Pericarditis and Shares Corporate Strategy Update!

Breaking News: Kiniksa Pharmaceuticals Unveils Exciting New Drug for Recurrent Pericarditis and Shares Corporate Strategy Update! Description: Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025. KPL-387 Phase 1 single ascending dose data support potential monthly dosing. Kiniksa continues to focus development on

Read More »

Breaking Down the Numbers: A Recap of LTC’s 2024 Fourth Quarter Performance

Breaking Down the Numbers: A Recap of LTC’s 2024 Fourth Quarter Performance Description: WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC Properties, Inc. (NYSE: LTC) (“LTC” or the “Company”), a real estate investment trust that primarily invests in seniors housing and health care properties, today announced operating results for the fourth quarter ended December

Read More »

Breaking News: EQT Corporation’s Exciting Exchange Offers and Consent Solicitations for EQM Midstream Partners LP Notes!

Breaking News: EQT Corporation’s Exciting Exchange Offers and Consent Solicitations for EQM Midstream Partners LP Notes! Description: PITTSBURGH, Feb. 24, 2025 /PRNewswire/ — EQT Corporation (NYSE: EQT) (“EQT” and, collectively with its consolidated subsidiaries, the “Company”) today announced that it has commenced offers to Eligible Holders (as defined below) to

Read More »

SEARCH

Receive the latest market news

Subscribe To Our Newsletter

Get notified about market movers